Graph theory analysis reveals how sickle cell disease impacts neural networks of patients with more severe disease

被引:13
|
作者
Case, Michelle [1 ]
Shirinpour, Sina [1 ]
Vijayakumar, Vishal [2 ]
Zhang, Huishi [1 ]
Datta, Yvonne [3 ]
Nelson, Stephen [4 ]
Pergami, Paola [5 ]
Darbari, Deepika S. [6 ]
Gupta, Kalpna [3 ]
He, Bin [1 ,7 ]
机构
[1] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[4] Childrens Hosp & Clin Minnesota, Dept Hematol Oncol, Minneapolis, MN USA
[5] Childrens Natl Hlth Syst, Dept Neurol, Washington, DC USA
[6] Childrens Natl Hlth Syst, Div Hematol, Washington, DC USA
[7] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA
关键词
Sickle cell disease; Electroencephalography (EEG); Functional magnetic resonance imaging (fMRI); Graph theory; Resting state; RESTING-STATE EEG; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; PAIN; CHILDREN; ANEMIA; SENSITIZATION; LOCALIZATION; ACTIVATION; FREQUENCY;
D O I
10.1016/j.nicl.2018.11.009
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Sickle cell disease (SCD) is a hereditary blood disorder associated with many life-threatening comorbidities including cerebral stroke and chronic pain. The long-term effects of this disease may therefore affect the global brain network which is not clearly understood. We performed graph theory analysis of functional networks using non-invasive fMRI and high resolution EEG on thirty-one SCD patients and sixteen healthy controls. Resting state data were analyzed to determine differences between controls and patients with less severe and more severe sickle cell related pain. fMRI results showed that patients with higher pain severity had lower clustering coefficients and local efficiency. The neural network of the more severe patient group behaved like a random network when performing a targeted attack network analysis. EEG results showed the beta1 band had similar results to fMRI resting state data. Our data show that SCD affects the brain on a global level and that graph theory analysis can differentiate between patients with different levels of pain severity.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Characterization of Sensorineural Hearing Loss in Adult Patients With Sickle Cell Disease: A Systematic Review and Meta-analysis
    Kapoor, Elina
    Strum, David
    Shim, Timothy
    Kim, Sunny
    Sabetrasekh, Parisa
    Monfared, Ashkan
    OTOLOGY & NEUROTOLOGY, 2021, 42 (01) : 30 - 37
  • [32] Multivariate surface-based analysis of corpus callosum in patients with sickle cell disease
    Chai, Yaqiong
    Lao, Yi
    Li, Yicen
    Ji, Chaoran
    O'Neil, Sharon
    Wang, Yalin
    Lepore, Natasha
    Wood, John
    12TH INTERNATIONAL SYMPOSIUM ON MEDICAL INFORMATION PROCESSING AND ANALYSIS, 2017, 10160
  • [33] The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression
    Allard, Pierre
    Tagliaferri, Laura
    Weru, Vivienn
    Cario, Holger
    Lobitz, Stephan
    Grosse, Regine
    Bleeke, Matthias
    Oevermann, Lena
    Hakimeh, Dani
    Jarisch, Andrea
    Kopp-Schneider, Annette
    Kulozik, Andreas E.
    Kunz, Joachim B.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 501 - 509
  • [34] Sickle Cell Disease Severity Prediction from Percoll Gradient Images Using Graph Convolutional Networks
    Sadafi, Ario
    Makhro, Asya
    Livshits, Leonid
    Navab, Nassir
    Bogdanova, Anna
    Albarqouni, Shadi
    Marr, Carsten
    DOMAIN ADAPTATION AND REPRESENTATION TRANSFER, AND AFFORDABLE HEALTHCARE AND AI FOR RESOURCE DIVERSE GLOBAL HEALTH (DART 2021), 2021, 12968 : 216 - 225
  • [35] Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey
    Osunkwo, Ifeyinwa
    James, John
    El-Rassi, Fuad
    Nero, Alecia
    Minniti, Caterina P.
    Trimnell, Cassandra
    Paulose, Jincy
    Ramscar, Nicholas
    Bailey, Tom
    Rajkovic-Hooley, Olivera
    Andemariam, Biree
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : 1055 - 1064
  • [36] Impact of scheduled partial exchange transfusions on outcomes in pregnant patients with severe sickle cell disease: a retrospective study
    Ananthaneni, Anil
    Jones, Sarah
    Ghoweba, Mohamed
    Grant, Vishwa
    Leethy, Kenna
    Benzar, Taras
    Master, Samip
    Mansour, Richard
    Ramadas, Poornima
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S109 - S114
  • [37] Graph neural networks for electroencephalogram analysis: Alzheimer's disease and epilepsy use cases
    Abadal, Sergi
    Galvan, Pablo
    Marmol, Alberto
    Mammone, Nadia
    Ieracitano, Cosimo
    Lo Giudice, Michele
    Salvini, Alessandro
    Morabito, Francesco Carlo
    NEURAL NETWORKS, 2025, 181
  • [38] Lumbar Fusions in Patients with Sickle Cell Disease: A Propensity-Matched Analysis of Postoperative Complications
    Liu, Kevin G.
    Ton, Andy T.
    Brown, Michael
    Mertz, Kevin
    Patel, Siddharth
    Shelby, Hannah
    Gettleman, Brandon
    Ragheb, Jonathan M.
    Mills, Emily S.
    Wang, Jeffrey C.
    Hah, Raymond J.
    Alluri, Ram K.
    WORLD NEUROSURGERY, 2024, 190 : E435 - E442
  • [39] Prevalence of Sensorineural Hearing Loss in Pediatric Patients with Sickle Cell Disease: A Meta-analysis
    Strum, David
    Kapoor, Elina
    Shim, Timothy
    Kim, Sunny
    Sabetrasekh, Parisa
    Monfared, Ashkan
    LARYNGOSCOPE, 2021, 131 (05) : 1147 - 1156
  • [40] Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease
    Rangarajan, Hemalatha G.
    Abu-Arja, Rolla
    Pai, Vinita
    Guilcher, Gregory M. T.
    Soni, Sandeep
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) : 413 - 417